fgen stock price target

The average price target is 196 which means analysts expect the stock to climb by 3084 over the next twelve months. Price Target and Analyst Ratings.

Fibrogen Nasdaq Fgen Stock Price News Charts Benzinga

The firm has a market capitalization of 136 billion a price-to-earnings ratio of -628 and a beta of 083.

. On Sep 22 2021 The Goldman Sachs Group gave 1600 - 1100 rating for FGEN. Find the latest FibroGen Inc FGEN stock price forecast 12-month price target predictions and analyst recommendations. 70 rows The average price target is 2543 with a high forecast of 4500 and a low forecast.

The highest average and lowest price target of all analysts. Over the past 83 months FGENs priceearnings ratio has gone up 296. On average analysts give the stock a Hold rating.

6 Wall Street analysts that have issued a 1 year FGEN price target the average FGEN price target is 2883 with the highest FGEN stock price forecast at 4500 and the lowest FGEN stock price forecast at 1100. 073 Spread Average Target. The Trend in the Analyst Price Target FGENs average price target has moved down 3965 over the prior 20 months.

The price target was changed from 1124 to 03. The average price target is 2500 with a high forecast of 2500 and a low forecast of 2500. Below are key valuation metrics over time for FGEN.

FGEN was reported by Goldman Sachs on September 22 2021. The average price target represents a 5733 change from the last price of 1589. The analyst firm set a price target for 1100 expecting FGEN to fall to within 12 months.

FibroGen stock price target cut to 29 from 72 at Mizuho. Their forecasts range from 1100 to 4500. The Company is engaged in discovering developing and commercializing a pipeline of first-in-class therapeutics.

FGENPH updated stock price target summary. News First Gen CorpFGEN. No significant news for in the past two years.

Wall Street is neutral on FibroGen Inc FGEN. Over the past 38 weeks FGENs average upside potential has been 6512. The average twelve-month price target for FibroGen is 2543 with a high price target of 4500 and a low price target of 1100.

That average ranking earns the stock an Analyst Rating of 4 which is better. 051 Average target price. Find the latest FibroGen Inc FGEN analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

The latest price target for. Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate. 093 Spread Highest target.

The Company applies its capabilities in hypoxia-inducible factor HIF biology 2-oxoglutarate enzymology and connective. 10 Wall Street analysts have issued 1-year price targets for FibroGens stock. In-depth view of key statistics and finances for FIBROGEN INC.

Analyst Price Target on FGEN. Is a biopharmaceutical company. ET by Tomi Kilgore.

FGEN on MSN Money. 7 2021 at 722 am. Thursday February 17 2022 0411 PM InvestorsObserver Analysts.

On average they anticipate FibroGens stock price to reach 2543 in the next twelve months. Based on analysts offering 12 month price targets for FGEN in the last 3 months. The companys fifty day moving average is 1459 and its two-hundred day moving average is 1284.

Get the latest Zacks research report on FGEN FREE. FGENs EVEBIT ratio has moved up 431 over the prior 83 months. Stock Price Forecast The 5 analysts offering 12-month price forecasts for FibroGen Inc have a median target of 1500 with a high estimate of 2500 and a low estimate of 1100.

The average price target is 000 with a high estimate of 000 and a low estimate of 000. Based on 2 Wall Street analysts offering 12 month price targets for FibroGen in the last 3 months. The median FGEN price target a different metric than the average or mean was 150 as of 2022-01-17 the highest FGEN price target in the range was 290 while the lowest FGEN price target in the range was 140 with a standard deviation of 7861.

This suggests a possible upside of 738 from the stocks current price. High Price Target. FibroGen has a 52-week low of 988 and a 52-week high of 5425.

NASDAQ FGEN opened at 1463 on Monday. Dow Jones a News Corp company About WSJ. Learn more on FGENs analyst rating history Do Wall Street analysts like FibroGen more than its competitors.

10 ETFs With Most Upside To Analyst Targets. The Price to Earnings PE ratio a key valuation measure is calculated by. News Corp is a global diversified media and information services company focused on creating and distributing.

In comparison to the median Healthcare stock FGENs pricesales ratio is 4449 lower now standing at 63.

Hekb9y6 F7yehm